This inventor holds 2 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Ceva Sante Animale. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Marie Varloud: Innovator in Veterinary Compositions
Introduction
Marie Varloud is a prominent inventor based in Libourne, France. She has made significant contributions to the field of veterinary medicine, particularly in the development of compositions for controlling ectoparasites in non-human mammals. With a total of 2 patents, her work is vital for improving animal health and welfare.
Latest Patents
Marie Varloud's latest patents include innovative solutions for veterinary applications. One of her notable inventions is titled "Compositions and uses thereof for controlling ectoparasites in non-human mammals." This invention focuses on novel veterinary compositions that comprise an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The use of these compositions aims to effectively control ectoparasites in non-human mammals. Another significant patent is "Methods for controlling the spread of dirofilariosis." This invention outlines a method for controlling the spread of dirofilariosis, such as heartworm, by administering a combination of a neonicotinoid compound and a pyrethroid compound to non-human animals infested with filarioid nematodes.
Career Highlights
Marie Varloud is associated with Ceva Santé Animale, a company dedicated to animal health. Her work at this organization has allowed her to focus on developing effective veterinary solutions that address critical health issues in animals.
Collaborations
Throughout her career, Marie has collaborated with notable colleagues, including Hamadi Karembe and Elizabeth Hodgkins. These collaborations have contributed to the advancement of her research and the successful development of her patents.
Conclusion
Marie Varloud is a key figure in veterinary innovation, with her patents playing a crucial role in enhancing animal health. Her contributions continue to impact the field positively, ensuring better care for non-human mammals.